Federal Supply Schedule 36F79721D0136
Award Date
4/1/21
Last Date to Order
3/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Zogenix, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract, awarded to First Nation Group LLC, a veteran-owned and service-disabled veteran-owned small business, provides drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs (VA) and its Veterans Integrated Service Network 12 (VISN 12). The $225,000.00 contract has a performance period from September 15, 2024, to September 14, 2029. The price list includes a variety of pharmaceutical products, such as Cyclobenzaprine HCL...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Urovant Sciences Inc., a subsidiary of Sumitovant Biopharma, Inc. This multiple-award contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under FSS-61-IB. The contract has a potential value of $700,000.00 and a period of performance through September 14, 2026. The contract aims to provide the Department...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA), provides Supernus Pharmaceuticals, Inc. a five-year, $132.6 million ceiling to supply drugs, pharmaceuticals, and hematology-related products to VA medical facilities. As a multiple award schedule (MAS) contract under FSS-61-IB, it allows the VA to directly order pre-negotiated products from Supernus's catalog to efficiently meet the...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Pharmaceuticals and Drugs (FSS-61-IB) to the agency's Veterans Integrated Service Network 12. The prime contractor, Avion Pharmaceuticals, LLC, was awarded this multiple-award contract with a ceiling value of $675,000.00 and a period of performance through December 31, 2025. The contracted products and services encompass a broad range of pharmaceutical and hematology-related items....
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Scilex Pharmaceuticals Inc., a for-profit organization, on March 1, 2019. The contract has a ceiling value of $300,000.00 and an ultimate completion date of January 31, 2026. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract...